Implementing the 2017 WHO Cancer Resolution: Time to acknowledge the critical role of pathology & laboratory medicine services?
In 2012, cancer was the second leading cause of mortality in the world with 8.2 million cancer-related deaths.
In 2012, cancer was the second leading cause of mortality in the world with 8.2 million cancer-related deaths. The annual number of new cancer cases is projected to increase to 21.6 million by 2030 and has led to cancer becoming a major public concern.
At the World Health Assembly (WHA) in May 2017, health leaders from around the globe reaffirmed cancer control as a critical health and development priority. They unanimously adopted a new Cancer Resolution aimed at providing countries with guidance, not only on health promotion and risk factor reduction, but also on the need to address inequity in access to early diagnosis and detection, appropriate treatment and prevention.
Chaired by Dr Suzy Lishman, this webinar brings together an international panel of speakers to discuss the critical role that pathology and laboratory medicine services must play in realising the commitments set out in the 2017 WHO Cancer Resolution and global efforts on cancer control. Drawing on their knowledge and experiences, panellists will explore and debate ways to ensure that national cancer control plans adequately address the provision of effective and affordable pathology services.
Learning Objectives of Webinar
- To develop a thorough understanding of the 2017 WHO Cancer Resolution within the context of the Global Action Plan on Non-Communicable Diseases and the United Nations (UN) Sustainable Development Goals (SDGs) 2030.
- To discuss and explore possible initiatives and strategies aimed at influencing and raising awareness amongst key decision-makers and funders of the need to improve access to pathology services as a critical component of cancer control action plans; and
- To highlight examples of best practice in terms of what works.
